NYSE:HQL Abrdn Life Sciences Investors (HQL) Stock Price, News & Analysis $11.80 +0.14 (+1.21%) Closing price 04/17/2025 03:59 PM EasternExtended Trading$11.82 +0.02 (+0.16%) As of 04/17/2025 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsDividendHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Abrdn Life Sciences Investors Stock (NYSE:HQL) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get HQL alerts:Sign Up Key Stats Today's Range$11.72▼$11.8350-Day Range$10.81▼$14.2752-Week Range$10.55▼$15.90Volume61,175 shsAverage Volume101,120 shsMarket Capitalization$340.72 millionP/E RatioN/ADividend Yield12.46%Price TargetN/AConsensus RatingN/A Company OverviewAbrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as market position for services or products, experience of business management, technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotech Index and the S&P 500 Index. Abrdn Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States.Read More… Receive HQL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Abrdn Life Sciences Investors and its competitors with MarketBeat's FREE daily newsletter. Email Address HQL Stock News HeadlinesInsider Selling: Abrdn Life Sciences Investors (NYSE:HQL) Major Shareholder Sells 15,400 Shares of StockApril 16, 2025 | insidertrades.comAbrdn Life Sciences Investors (NYSE:HQL) Major Shareholder Saba Capital Management, L.P. Sells 30,156 SharesApril 15, 2025 | insidertrades.comNew “Trump” currency proposed in DCFormer Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans a chance at true financial independence in the months ahead.” We recently sat down with Rickards to capture all the key details on tape. April 20, 2025 | Paradigm Press (Ad)Insider Selling: Abrdn Life Sciences Investors (NYSE:HQL) Major Shareholder Sells 6,889 Shares of StockApril 8, 2025 | insidertrades.comInsider Selling: Abrdn Life Sciences Investors (NYSE:HQL) Major Shareholder Sells 29,102 Shares of StockApril 4, 2025 | insidertrades.comSaba Capital Management sells $502k in abrdn Life Sciences Investors stockFebruary 13, 2025 | msn.comAbrdn life sciences investors sees $871,708 in stock sales by Saba CapitalFebruary 12, 2025 | msn.comHQL: Attractive Valuation, Aligned To Benefit From Aging Gen XFebruary 11, 2025 | seekingalpha.comSee More Headlines HQL Stock Analysis - Frequently Asked Questions How have HQL shares performed this year? Abrdn Life Sciences Investors' stock was trading at $13.12 on January 1st, 2025. Since then, HQL shares have decreased by 10.1% and is now trading at $11.8010. View the best growth stocks for 2025 here. Who are Abrdn Life Sciences Investors' major shareholders? Top institutional investors of Abrdn Life Sciences Investors include 180 Wealth Advisors LLC (0.50%), Wealthcare Advisory Partners LLC (0.04%) and Parallel Advisors LLC (0.02%). Insiders that own company stock include Saba Capital Management, LP, Daniel R Omstead, Kathleen Goetz, Todd Reit and Rose Dimartino. View institutional ownership trends. How do I buy shares of Abrdn Life Sciences Investors? Shares of HQL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Abrdn Life Sciences Investors own? Based on aggregate information from My MarketBeat watchlists, some other companies that Abrdn Life Sciences Investors investors own include Rithm Capital (RITM), DoubleLine Income Solutions Fund (DSL), Medical Properties Trust (MPW), Verizon Communications (VZ), International Business Machines (IBM), Eaton Vance Tax-Managed Global Diversified Equity Income Fund (EXG) and Energy Transfer (ET). Company Calendar Record date for 3/31 Dividend2/21/2025Ex-Dividend for 3/31 Dividend2/21/2025Dividend Payable3/31/2025Today4/20/2025Next Earnings (Estimated)6/09/2025Fiscal Year End9/30/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorFinance Industry Investment offices, not elsewhere classified Sub-IndustryFinancial Services Current SymbolNYSE:HQL CIK884121 Webwww.teklacap.com Phone(617) 772-8500Fax617-772-8577EmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$86.69 million Price / Sales3.93 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares28,872,000Free Float24,599,000Market Cap$340.72 million OptionableNot Optionable Beta0.80 10 Stocks Set to Soar in Spring 2025Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free Report This page (NYSE:HQL) was last updated on 4/20/2025 by MarketBeat.com Staff From Our PartnersThe real reason gold is soaring (and likely to continue)Trump’s Policies Are Fueling a Gold Boom—Here’s Your Chance to Profit Donald Trump’s bold policies are driv...Golden Portfolio | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredThe first casualty of the 2025 trade warThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Abrdn Life Sciences Investors Please log in to your account or sign up in order to add this asset to your watchlist. Share Abrdn Life Sciences Investors With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.